inflammatory activity (IA) is a cause of hypoalbuminemia in patients with acute heart failure (AHF).

the main objective of this study was to evaluate whether an AI modulator treatment contributes to correcting albuminemia in this context.

in this clinical trial 43 patients with AHF, hypoalbuminemia (serum albumin  3.4 g/dl), and e…[Read more]

management of musculoskeletal injuries in professional and Olympic athletes. There is currently insufficient high-level evidence to support the widespread use of biologic therapies in athletes. Further research priorities include the development of condition/pathology-specific preparations of biologic therapies, and of outcome measures and imaging…[Read more]